Evaluation of Votrient in Angiosarcoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2019

Study Completion Date

July 1, 2020

Conditions
Angiosarcoma
Interventions
DRUG

Pazopanib + Paclitaxel

pazopanib in combination with paclitaxel in the treatment of patients with advanced or metastatic angiosarcoma.

Trial Locations (10)

Unknown

Universitätsklinik Graz, Graz

Universitätsklinik Wien, Vienna

Helios-Klinikum Bad Saarow, Bad Saarow

Helios Klinikum Berlin-Buch, Berlin

Universitätsklinikum Carl Gustav Carus, Dresden

Universitätsklinikum Essen, Essen

Universitätsklinikum Hamburg-Eppendorf, Hamburg

Medizinische Hochschule Hannover, Hanover

University Medical Center, Mannheim

Klinikum der Universität München Campus Großhadern, München

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Universitätsmedizin Mannheim

OTHER

collaborator

Helios Klinikum Berlin-Buch

OTHER

collaborator

University Hospital Dresden

OTHER

collaborator

Universitätsklinikum Hamburg-Eppendorf

OTHER

collaborator

University Hospital, Essen

OTHER

collaborator

Hannover Medical School

OTHER

collaborator

Klinikum der Universitaet Muenchen, Grosshadern

OTHER

collaborator

Medical University of Vienna

OTHER

collaborator

Medical University of Graz

OTHER

collaborator

Medical University Innsbruck

OTHER

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Heidelberg University

OTHER